[癌症恶性通过异常的克劳丁表达]
1Laboratory of Biochemistry, Dept. of Biopharmaceutical Sciences, Gifu Pharmaceutical University.
Gan to kagaku ryoho. Cancer & chemotherapy
|December 8, 2024
概括
克劳丁 (CLDNs) 是参与细胞结合的蛋白质,在肺癌和结直肠癌中表达高. 抑制CLDNs可以通过向氧化应激和Nrf2通路来减少癌症的扩散,并改善化疗耐药性.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 克劳丁蛋白 (CLDNs) 是紧密的结节蛋白,在各种固体瘤中表达高.
- 确切的机制和CLDNs在癌症中的病理生理作用仍然不完全理解.
研究的目的:
- 研究特定的克劳丁亚型 (CLDN2和CLDN14) 在肺腺癌和结直肠癌中的作用.
- 阐明CLDNs影响癌细胞增殖和化学抵抗的机制.
主要方法:
- 在癌细胞系中对CLDN表达的比较分析.
- 在3D球形中评估CLDN对癌细胞增殖和化学抵抗的影响.
- 研究氧化应激和Nrf2信号通路的参与.
主要成果:
- 发现CLDN2和CLDN14在肺腺癌和结直肠癌细胞中分别表达高.
- 升高的CLDN表达增加了癌细胞的增殖.
- 通过增加氧化应激和Nrf2通路激活,CLDNs通过增加氧化应激和Nrf2通路激活,增强了癌症球体中的化学抵抗.
- 依赖CLDN2的Nrf2激活涉及葡萄糖代谢的转变和线粒体活动的增加.
结论:
- 克劳丁表达在促进癌细胞增殖和化学抵抗方面发挥着重要作用.
- 针对CLDNs,可能通过抑制剂,可以提供抑制增殖和克服耐药性的治疗策略.
- 需要进一步的研究来确定最佳的CLDN亚型作为治疗点,因为癌症类型的表达模式各不相同.
相关概念视频
Cadherins in Tissue Organization
2.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
2.9K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Tight Junctions
5.2K
Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
5.2K
Cancer
47.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


